I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Transplantation is a renal replacement therapy in patients with end-stage renal disease (ESRD). Arterial pseudoaneurysm or arterial rupture of the transplanted renal artery is an extremely rare but potentially devastating complication which occurs in fewer than 1% of patients \[[@ref1]\]. They may cause functional impairment or death. We describe two patients who underwent renal transplantation from the same deceased multiorgan donor and both developed early vascular complications.

C[ASE REPORTS]{.smallcaps} {#sec1-2}
==========================

Case 1 {#sec2-1}
------

A 49-year-old woman with ESRD underwent a cadaveric renal transplant in our department. The kidney was transplanted with an end-to-side anastomosis of the transplant renal artery to the right external iliac artery. Her postoperative condition was uneventful, and the drainage tube was removed on postoperative day 10. However, sudden onset of the right lower abdominal pain occurred 14 days after the operation. Physical examination revealed a distended right lower abdomen without tenderness. There was no significant decrease in the hematocrit. Emergency abdominal computed tomography revealed a large extraperitoneal perinephric renal hematoma. An emergency exploratory laparotomy showed a large number of fresh blood clots and a ruptured graft renal artery; a major 1 cm wide rupture was found at the middle part of the graft artery next to four more tiny leakage points. The arterial rupture was closed primarily with a 5-0 prolene suture, and fibrin sealant (TISSEEL^®^, Baxter AG, Vienna, Austria) was applied to strengthen the vascular wall after vessel repair.

Culture of the central venous catheter tip showed *Candida albicans*, and antifungal medication applied. A Doppler ultrasound revealed the graft renal vessels were patent with adequate perfusion of the graft kidney after surgical reconstruction. Renal function gradually recovered with adequate daily urine output 1 month after the operation. However, another episode of septic shock with right lower quadrant abdominal pain occurred 1 month later. An emergency exploratory laparotomy showed massive pus-like fluid around the graft kidney with fungal and bacterial infection confirmed by culture. Necrotic tissue around the graft artery and external iliac artery was observed. A graft nephrectomy was done and the external iliac artery was repaired with a graft patch.

Case 2 {#sec2-2}
------

The second recipient was a 56-year-old woman with hypertension. The patient had a history of ESRD and had undergone hemodialysis for years. She also received renal transplantation on the same day as Case 1 with similar procedures. She had good graft function and was discharged early. However, decreased urine output and bilateral lower leg edema were noted 32 days after the operation. Compromised renal function was observed. Renal ultrasonography showed a 3 cm hypoechoic mass with a centrally anechoic lesion around the graft renal artery \[[Figure 1a](#F1){ref-type="fig"}\]. Color-coded Doppler sonography revealed pulsatile flow within the central anechoic part of the lesion \[[Figure 1b](#F1){ref-type="fig"}\]. The possible diagnosis was a pseudoaneurysm, which partially thrombosed the true lumen of the graft renal artery. Subsequent noncontrast magnetic resonance imaging confirmed a 3 cm × 3 cm false aneurysm near the anastomosis of the transplanted renal artery \[[Figure 2](#F2){ref-type="fig"}\]. Surgical exploration showed an aneurysmal mass along the anastomosis site near the external iliac artery. Scrupulous dissection isolated the false aneurysm from the transplanted kidney. Vascular control was obtained, and resection of the false aneurysm was then performed. Vascular repair was performed with a primary anastomosis at the external iliac artery and transplanted renal artery using a continuous 5-0 nonabsorbable suture (polypropylene). Fibrin sealant was also applied to the reanastomosis site to prevent vascular leakage.

![(a and b) Demonstrate a hypoechoic lesion with a central anechoic lesion near the transplanted renal artery. A pulsatile flow pattern was seen on color-coded Doppler sonography within the central anechoic part of the lesion](TCMJ-30-250-g001){#F1}

![Noncontrast T2-weighted magnetic resonance imaging reveals a pseudoaneurysm (white arrow) with compression of the true lumen of the transplanted renal artery (white arrowhead), causing poor flow in the transplanted kidney](TCMJ-30-250-g002){#F2}

Histopathology of the resected pseudoaneurysm wall showed consistent marked fibrosis and fragmentation of elastic fibers. *C. albicans* was cultured from the drainage fluid. The patient was continued on immunosuppressive therapy and antifungal medication and was discharged home under stationary condition.

D[ISCUSSION]{.smallcaps} {#sec1-3}
========================

Vascular complications are rare in renal transplantation patients but are significant causes of allograft loss. We conducted a comprehensive search to identify all relevant studies of extrarenal vascular pseudoaneurysm or arterial rupture in the MEDLINE (1950 -- November 4, 2016) and EMBASE (1970 -- November 4, 2016) databases. A total of 45 case reports or case series that met the inclusion criteria were reviewed \[[Table 1](#T1){ref-type="table"}\]. According to our literature review, the mortality rate was 13.8%. A major proportion (56.3%) of reported cases lost the graft kidney without mortality. Among the 87 patients, 73 (83.9%) experienced vascular complications at the anastomosis site. The majority of included patients (79.3%) were diagnosed with pseudoaneurysm, and 18 out of 87 patients (20.7%) had an arterial rupture. Only 33 patients (37.9%) had no infective pathogens. *C. albicans* (24 cases) was the leading pathogen in cases with infection. In our 2 cases, pseudoaneurysm occurred around the anastomosis site, while the ruptured site was at the middle portion of the graft artery in case 1, which is less common arterial than at other sites \[[Table 1](#T1){ref-type="table"}\].

###### 

Extrarenal vascular pseudoaneurysm and arterial rupture following renal transplantation in the literature

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   Author                                 Year   Aneurysm site           Infection                         Interval after transplant   Number/intervention                          Outcome
  -------- -------------------------------------- ------ ----------------------- --------------------------------- --------------------------- -------------------------------------------- ---------------------------------
  1        Kyriakides *et al*.\[[@ref2]\]         1976   5/AS\                   4/*E. coli*\                      1.5-6 months                8/Tx\                                        2/death 6/graft loss
                                                         3/AS (ruptured)         2/*C. albicans*\                                              1/SR                                         
                                                                                 2/*Pseudomonas* spp.                                                                                       

  2        Renigers and Spigos\[[@ref3]\]         1978   1/AS                    1/none                            28 days                     1/Tx                                         1/graft loss

  3        Benoit *et al*.\[[@ref4]\]             1988   1/AS                    1/none                            6 months                    1/Tx                                         1/graft loss

  4        Koo *et al*.\[[@ref5]\]                1999   3/AS                    1/*S*. *aureus* (MRSA)\           2-3 months                  1/endovascular coil embolization\            1/graft loss\
                                                                                 2/none                                                        1/Tx\                                        2/graft preserved
                                                                                                                                               1/OBS                                        

  5        Battaglia *et al*.\[[@ref6]\]          2000   1/AS (ruptured)\        2/*C*. *albicans*                 17 days-3 months            2/Tx                                         2/graft loss
                                                         1/AS                                                                                                                               

  6        Reus *et al*.\[[@ref7]\]               2002   1/AS                    1/none                            2 months                    1/thrombin injection                         1/graft loss (before procedure)

  7        Garrido *et al*.\[[@ref8]\]            2003   1/AS\                   2/*Aspergillus* spp.              1.5-4 months                2/Tx                                         1/Sudden death\
                                                         1/EIA                                                                                                                              1/graft loss

  8        Peel *et al*.\[[@ref9]\]               2003   1/EIA                   1/*C.* *albicans*                 1 month                     1/SR + EVS                                   1/graft preserved

  9        Taghavi *et al*.\[[@ref10]\]           2005   1/AS                    1/none                            72 months                   1/SR                                         1/graft preserved

  10       Laouad *et al*.\[[@ref11]\]            2005   4/AS                    4/*C*. *albicans*                 9 days-3 months             4/Tx                                         3/graft loss\
                                                                                                                                                                                            1/Sudden death

  11       Zavos *et al*.\[[@ref12]\]             2005   1/AS\                   2/none                            5 months                    2/EVS                                        2/graft loss
                                                         1/AS (ruptured)                                                                                                                    

  12       Fujikata *et al*.\[[@ref13]\]          2006   1/AS                    1/*S*. *aureus* (MRSA)            1.3 months                  1/OBS                                        1/graft preserved

  13       Fujita *et al*.\[[@ref14]\]            2006   1/AS (ruptured)         1/none                            5 months                    1/EVS                                        1/graft preserved

  14       Nguan and Luke\[[@ref15]\]             2006   1/AS                    1/*S*. *aureus*                   \-                          1/Tx                                         1/graft loss

  15       Siu *et al*.\[[@ref16]\]               2006   1/AS                    1/none                            3 months                    1/EVS + thrombin injection                   1/graft preserved

  16       Fornaro *et al*.\[[@ref17]\]           2007   1/IA                    1/none                            15 months                   1/thrombin injection                         1/graft preserved

  17       Poels and Riley\[[@ref18]\]            2007   1/IA                    1/*Pseudomonas* spp.              1.7 months                  1/EVS + thrombin injection                   1/graft preserved

  18       Gravante *et al*.\[[@ref19]\]          2008   1/AS                    1/none                            6 months                    1/SR                                         1/graft preserved

  19       Orlić *et al*.\[[@ref20]\]             2008   1/AS                    1/none                            2.5 months                  1/Tx                                         1/graft loss

  20       Bracale *et al*.\[[@ref21][@ref22]\]   2009   5/AS\                   2/*C.* *albicans*\                13 days-49 months           8/Tx\                                        8/graft loss\
                                                         1/AS (ruptured) 6/EIA   1/*E. coli* 9/none                                            3/EVS + Tx\                                  3/death after OP\
                                                                                                                                               1/SR + replantation                          1/graft preserved

  21       Liu *et al*.\[[@ref23]\]               2009   1/AS                    1/*Aspergillus* spp.              12 months                   1/Tx                                         1/graft loss

  22       Orlando *et al*.\[[@ref24]\]           2009   2/AS (ruptured)         2/*Pseudomonas* spp.              11 days-21 days             2/Tx                                         2/death

  23       Osmán *et al*.\[[@ref25]\]             2009   1/AS                    1/*C. albicans*                   1.2 months                  1/EVS + Tx                                   1/graft loss

  24       Sharron *et al*.\[[@ref26]\]           2009   1/AS                    1/none                            3 months                    1/thrombin injection + SR                    1/graft preserved

  25       Wang *et al*.\[[@ref27]\]              2009   2/AS (ruptured)\        4/*Aspergillus* spp.              10 days-1.5 months          4/Tx                                         4/graft loss
                                                         2/AS                                                                                                                               

  26       Al-Wahaibi *et al*.\[[@ref28]\]        2010   1/AS                    1/none                            4 months                    1/SR                                         1/graft preserved

  27       Akgul *et al*.\[[@ref29]\]             2011   1/AS                    1/none                            14 years                    1/endovascular treatment with coil           1/graft preserved

  28       Lee *et al*.\[[@ref30]\]               2011   1/AS                    1/*C*. albicans                   2 months                    1/Tx                                         1/graft loss

  29       Minz *et al*.\[[@ref31]\]              2011   2/AS                    2/*Aspergillus* spp.              1-5 months                  2/Tx                                         1/death\
                                                                                                                                                                                            1/graft loss

  30       Buimer *et al*.\[[@ref32]\]            2012   1/AS                    1/*E. coli*                       14 months                   1/SR                                         1/graft preserved

  31       Favelier *et al*.\[[@ref33]\]          2012   1/AS                    1/none                            36 months                   1/endovascular coil insertion and stenting   1/graft preserved

  32       Kountidou *et al*.\[[@ref34]\]         2012   1/AS                    1/*C*. *albicans*                 3 months                    1/SR                                         1/graft preserved

  33       Leonardou *et al*.\[[@ref35]\]         2012   2/TRA\                  2/*Pseudomonas* spp.\             3-15 months                 4/EVS + Tx                                   4/graft loss
                                                         2/AS                    1/*K*. *pneumonia*\                                                                                        
                                                                                 1/*C*. *albicans*                                                                                          

  34       Smeds *et al*.\[[@ref36]\]             2013   1/AS                    1/none                            72 months                   1/EVS                                        1/graft preserved

  35       Santangelo *et al*.\[[@ref37]\]        2013   6/AS                    2/*C*. *albicans* 4/none          1.5-10 months               1/SR + replantation 4/Tx\                    1/graft preserved\
                                                                                                                                               1/EVS +Tx                                    5/graft loss

  36       Chandak *et al*.\[[@ref38]\]           2014   1/TRA (ruptured)        1/*Pseudomonas* spp.              10 days                     1/SR                                         1/graft preserved

  37       Che *et al*.\[[@ref39]\]               2014   1/EIA                   1/E. coli                         4 months                    1/EVS                                        1/graft preserved

  38       Dębska-Ślizień *et al*.\[[@ref40]\]    2015   2/AS (ruptured)         2/*C.* *albicans*                 10 days-1 month             2/Tx                                         2/death after OP

  39       Madhav *et al*.\[[@ref41]\]            2015   1/AS                    1/*C*. *albicans*                 25 days                     1/SR                                         1/graft preserved

  40       Patil *et al*.\[[@ref42]\]             2015   1/AS                    1/*E. coli*                       21 days                     1/EVS                                        1/graft preserved

  41       Patrono *et al*.\[[@ref43]\]           2015   2/AS (ruptured)\        2/*C*. *albicans*\                12 days-25 days             2/Tx\                                        2/graft loss\
                                                         1/AS                    1/*Pseudomonas* spp.                                          1/SR                                         1/graft preserved

  42       Tshomba *et al*.\[[@ref44]\]           2015   1/AS                    1/none                            9 months                    1/EVS                                        1/graft preserved

  43       Ardita *et al*.\[[@ref45]\]            2015   1/AS                    1/none                            20 days                     1/SR                                         1/graft preserved

  44       Zhao *et al*.\[[@ref46]\]              2016   2/AS (ruptured)         2/*C*. *albicans*                 14-21 days                  2/EVS + Tx                                   2/graft loss

           Summary                                       AS: 73 (17 ruptured)\   None: 33\                                                                                                  Graft preserved: 26\
                                                         EIA: 9 (0 ruptured)\    *C*.\                                                                                                      Graft loss: 49\
                                                         IA: 2 (0 ruptured)\     *albicans*: 24\                                                                                            Death: 12
                                                         TRA: 3 (1 ruptured)     *Aspergillus* spp.: 9\                                                                                     
                                                                                 *Pseudomonas* spp.: 9\                                                                                     
                                                                                 *E. coli*: 8\                                                                                              
                                                                                 *S*. *aureus*: 3 (with 2 MRSA)\                                                                            
                                                                                 K. pneumoniae: 1                                                                                           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AS: Anastomosis site, EIA: External iliac artery, TRA: Transplant renal artery, IA: Iliac artery, Tx: Transplantectomy, SR: Surgical repair, EVS: Endovascular stenting; OBS: Observation, *E. coli*: *Escherichia* *coli*, *C*. *albicans*: *Candida* *albicans*, *S. aureus*: *Staphylococcus* *aureus*, MRSA: Methicillin-resistant *S. aureus*, *K. pneumonia*: *Klebsiella pneumonia*

Patients with pseudoaneurysms after renal transplant are often asymptomatic and diagnosed incidentally \[[@ref20][@ref23]\]. Detecting infective pseudoaneurysm in the early course and starting immediate surgical treatment with antifungal medications are essential. *Candida* arteritis-related pseudoaneurysm or ruptures may progress rapidly in the early stage after transplantation \[[@ref11][@ref35][@ref37][@ref40]\]. This finding is different from that of those with chronic rejection-related transplant arterial pseudoaneurysm, which may be associated with a delayed course and relatively slow progression \[[@ref40]\]. One report suggested that 2-week preemptive prophylaxis with antifungal agents can effectively prevent delayed vascular complications in patients with donation-after-cardiac-death kidney transplantation complicated by fungal infection-related hemorrhage \[[@ref46]\]. Elimination of *C. albicans* is required to prevent possible arterial complications.

Surgical repair to preserve a transplanted kidney is not usually successful in vascular complications \[[@ref37]\]. We applied fibrin sealant for anastomosis, which seemed sufficient for control after surgical suturing for realignment of the vascular wall. No evident leakage was observed through daily drainage monitoring in both case 1 and case 2. This study is also the first to report successful use of fibrin sealant in securing injured transplant vessels.

C[ONCLUSION]{.smallcaps} {#sec1-4}
========================

The development of an extrarenal pseudoaneurysm or arterial rupture in a transplant renal artery is extremely rare. It can cause a potentially devastating allograft loss and may require allograft nephrectomy. For those with suspected vascular complications, early clinical diagnosis and aggressive surgical intervention are necessary to achieve better allograft outcome and patient survival.

Declaration of patient consent {#sec2-3}
------------------------------

The authors certify that all patients have obtained appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship {#sec2-4}
---------------------------------

Nil.

Conflicts of interest {#sec2-5}
---------------------

There are no conflicts of interest.
